By pioneering the development of targeted cancer drugs, Druker’s work helped usher in the practice of personalized cancer medicine
OHSU congratulates Brian J. Druker, MD, who has been awarded the 2012 Japan Prize in Healthcare and Medical Technology for his pioneering role in targeted cancer drugs. The Japan Prize is considered one of the world’s most prestigious awards in science and technology. Dr. Druker’s research proved it was possible to shut down cells that enable cancer to grow without harming healthy ones – a discovery that helped make once-fatal forms of the disease manageable.
“On behalf of all OHSU employees, I extend our congratulations to Brian,” said OHSU President Joe Robertson, MD, MBA. “Brian’s brilliance, hard work and dedication have impacted millions of lives. Though he has already achieved great things, Brian has maintained his fierce determination to make cancer a disease we no longer have to fear. It is impossible to not be inspired by him and want to be a part of his important mission to end cancer as we know it.”
The full OHSU media release is available online.